The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
North West (England); Greater Manchester; Greater Manchester North West
Location of affected unit(s)
Bolton
Sector
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.10 - Manufacture of basic pharmaceutical products
New offshoring locations
United States of America, Germany
150 jobs Number of planned job losses
Announcement Date
11 January 2021
Employment effect (start)
11 January 2021
Foreseen end date
11 October 2021
Description
Catalent UK, the British subsidiary of the US-based global pharmaceutical company, has confirmed that it will close its plant in Bolton, Greater Manchester, in the north west of England, over the next nine months. The closure will make 150 jobs redundant, which will be relocated to the company sites in the US, Germany and Bathgate, Scotland.
A representative of the company said the decision about the planned closure was made after reviewing the demand for clinical trial supply services in the UK.
A representative of the trade union Unite said the closure was due to the UK leaving the European Union and added that the job loss was a ‘blow’ to the employees and the local economy.
Catalent develops and manufactures drugs, gene therapies and consumer health products. It employs more than 14,000 people globally. The company currently has five sites across England and Scotland, with the Bolton site specialising in clinical trial supplies.
11 January 2021: Unite the Union (press release) (unitetheunion.org)
Citation
Eurofound (2021), Catalent, Offshoring/Delocalisation in United Kingdom, factsheet number 103198, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/103198.
Eurofound’s ERM restructuring legislation database offers an overview of key restructuring-related regulations in the EU Member States and Norway. Its content is continuously updated to reflect any changes made by national legislators in response to, for instance, policy shifts, legal...
Can Europe still achieve its ambitions for battery manufacturing? To answer this, the article looks at data from Eurofound’s European Restructuring Monitor and explores what recent large-scale restructuring events reveal about the state of play in the EU battery sector.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...